Cellecta, Incorporated

Biotech · Private

CRISPR/Cas9 genome-wide sgRNA library screening platform with experimental and bioinformatics tools for functional genomics

New patent · Oct 20

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · cellecta.com

Sector: Biotech
Total capital: $3.5M

Federal grants: $3.4M; 5 awards · 2015–2017; Rank in peer group#16 of 37
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $9K; 1 award · Health and Human S; Rank in Biotech#385 of 4373
Granted patents: 1; first 2026; Rank in peer group#8 of 37

Capital timeline

Latest events

Dec 2017Federal grantHealth and Human S · Phase II · CRISPR Genome-Wide sgRNA Library Screening Platform$844K
Dec 2016Federal grantHealth and Human S · Phase II · CRISPR Genome-Wide sgRNA Library Screening Platform$1.5M
Dec 2016Federal grantHealth and Human S · Phase II · CRISPR Genome-Wide sgRNA Library Screening Platform$652K
Jun 2015Federal grantHealth and Human S · Phase I · Open Resource CRISPR/CAS9 Genome-Wide sgRNA Library Screening Platform$225K
May 2015Federal grantHealth and Human S · Phase I · Open Resource CRISPR/CAS9 Genome-Wide sgRNA Library Screening Platform$225K
Apr 2015Federal contractHealth and Human S · Igf::cl::igf Cana-sqd - Sequencing/deconvolution Of Dna Samples From Shrna Library Screening$9K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 37 peers

Line = median

Biotech · Platform

Federal grants#16 · top 43%
Granted patents#8 · top 22%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 1

Oct 20, 2026New patentMultiplex Preparation of Barcoded Gene Specific DNA FragmentsUSPTOUS 12,767,975

Infinity Bio, Inc.Similar federal contract value in Biotech · $11K in contracts
seqWell Inc.Similar federal contract value in Biotech · $10K in contracts
Full Genomes CorpSimilar federal contract value in Biotech · $10K in contracts
Zenobia Therapeutics, Inc.Similar federal contract value in Biotech · $8K in contracts
RADIOMEDIX, INC.Similar federal contract value in Biotech · $5K in contracts
STEALTH BIOLOGICS LLCSimilar federal contract value in Biotech · $5K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.